Ken Herrmann

@ProfKHerrmann

Nuc Med - Theranostics - Innovation. Embracing Change.

Joined April 2022

303Following

1KFollowers

Pinned

Ken Herrmann Retweeted

Gianluca Giannarini@GGiannarini · Jun 18

Proud to be part of the family! @Albert0Briganti @LauraBukavinaMD @ChapinMD @MikkelFode @spsutkaMD @montypal @AmarUKishan @JelleBarentsz @ProfKHerrmann @declangmurphy @NikitaB0709 G. Thalmann @BartKiemeney M. Assel G. MacLennan @redunndant @VickersBiostats @CathyJPierce B. Neal

702

Ken Herrmann Retweeted

Michael Hofman@DrMHofman · Jul 26

Finally, a killer application for Y-90 FAPI theranostics? Near complete metabolic responses in 3 patients with treatment refractory solitary fibrous tumors. Ga-68 FAPI had high SUVs (117, 41, 31) with concordant FDG uptake. jnm.snmjournals.org/content/early/… @SNM_MI Wonderful work from…

6.0K

Ken Herrmann Retweeted

JNM@JournalofNucMed · Jul 21

SNMMI Annual Meeting Flashback: Johannes Czernin and Richard Wahl discuss trending topics in nuclear medicine. ow.ly/Fz2h50WocuN #NuclearMedicine #MolecularImaging #Theranostics #SNMMI25

606

Ken Herrmann Retweeted

Advanced Prostate Cancer Consensus Conference@APCCC_Lugano · Jul 9

A warm invite to the Advanced Prostate Cancer Consensus Conference #APCCC26 in Lugano🇨🇭 👉REGISTER HERE: apccc.org/apccc-2026/ In an era of rapid innovation and expanding treatment options for advanced #ProstateCancer , APCCC provides a vital forum for clinicians and…

6.0K

Ken Herrmann Retweeted

JNM@JournalofNucMed · Jul 1

¹⁸F-CTT1057 is effective in detecting PSMA-positive lesions, with high patient-level sensitivity and region-level specificity. ow.ly/uBa150W9YBZ #NuclearMedicine #MolecularImaging #ProstateCancer @stefanofanti4 @FrancescoCeci13 @NBuffi @PilarParedesMN

676

Ken Herrmann Retweeted

Johannes Czernin@CzerninJohannes · Jul 1

JNM Editors’ Choice Awards for 2024 | Journal of Nuclear Medicine jnm.snmjournals.org/content/66/7/9…

652

Ken Herrmann Retweeted

Johannes Czernin@CzerninJohannes · Jun 20

Summary: Appropriate Use Criteria for 18F-FDG PET/CT for Initial Staging of Malignant Disease | Journal of Nuclear Medicine jnm.snmjournals.org/content/early/…

469

Ken Herrmann Retweeted

JNM@JournalofNucMed · Jun 20

The current state of GRPR-targeted theranostics: from bench to bedside. ow.ly/hIsJ50VY3rG #NuclearMedicine #Theranostics @HeyingDuan

1.0K

Ken Herrmann Retweeted

JNM@JournalofNucMed · Jun 19

Routine dosimetry: Proceed with caution. ow.ly/qVHA50VY3q7 #NuclearMedicine #Dosimetry #RPTherapy @ProfKHerrmann @drlouiseemmett

464

Ken Herrmann Retweeted

JNM@JournalofNucMed · Jun 12

Continuing Education: Approaches to imaging immune activation using PET. ow.ly/vloI50VSPSh #PETscan #NuclearMedicine #MolecularImaging @DrAIravani @TheNUCguy

2.0K

Ken Herrmann Retweeted

onkowissen@onkowissen · Jun 6

Verpasst? Kein Problem! Die wichtigsten Erkenntnisse vom #ASCO25 gibt’s jetzt als Video on demand auf onkowissenTV ➡️ onkowissen.tv/beitraege/asco… @jcasusce @docchristoffer @GoebellJ @GriesingerFrank @grimm_mo @ProfHadaschik @HartkopfAndreas @ProfKHerrmann @IvanyiPhilipp…

467

Ken Herrmann Retweeted

JNM@JournalofNucMed · Jun 4

EDA-FN imaging with 89Zr-DFO-F8 exhibited powerful tumor delineation in preclinical triple-negative breast cancer models. ow.ly/oHFB50VKLFb #NuclearMedicine #MolecularImaging #TNBC @MSKCancerCenter @Just_Hachey @LewisLabMSKCC

576

Ken Herrmann Retweeted

JNM@JournalofNucMed · Jun 6

2024 SNMMI Highlights Lecture: Cardiovascular Sciences. ow.ly/Ja2150VKLT2 #NuclearMedicine #Cardiology #MedicalImaging #SNMMI24

829

Ken Herrmann Retweeted

OncoAlert@OncoAlert · Jun 3

Dear Colleagues at #ASCO25 As we gear up for an Exciting day of GU oncology here in Chicago, A warm invite from our partners at @APCCC_Lugano to Join us in Lugano🇨🇭Switzerland for the Advanced #ProstateCancer Consensus Conference. Here are @Silke_Gillessen & @AOmlin to tell us…

7.0K

Ken Herrmann Retweeted

OncoAlert@OncoAlert · Jun 1

Dear Colleagues at #ASCO25 A warm invite to Join us in LuganoSwitzerland for the Advanced Prostate Cancer Consensus Conference Here are @Silke_Gillessen & @AOmlin to tell us more REGISTER HERE 👉apccc.org @fabioturco92 @Prof_IanD @drjefstathiou @Prof_Nick_James…

2.0K

Ken Herrmann Retweeted

JNM@JournalofNucMed · May 12

Discussions with Leaders: John Babich, PhD, talks about new approaches to radiopharmaceutical development. ow.ly/8uaP50VuLVo #NuclearMedicine #RPTherapy #Theranostics

2.0K

Ken Herrmann Retweeted

OncoDaily@oncodaily · May 7

SBRT Safe for Oligometastases in Breast, Prostate, Colorectal - @piet_ost oncodaily.com/url/289259 #OncoDaily #Oncology #Cancer #Health #Medicine #MedX

999

Ken Herrmann Retweeted

Advanced Prostate Cancer Consensus Conference@APCCC_Lugano · May 8

Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2) sciencedirect.com/science/articl… In a large international multicenter study, researchers developed and validated…

5.0K

Ken Herrmann Retweeted

Johannes Czernin@CzerninJohannes · May 7

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update | Journal of Clinical Oncology ascopubs.org/doi/full/10.12…

328

Ken Herrmann Retweeted

JNM@JournalofNucMed · May 7

Instant single-time-point image-based dosimetry paves the way for improved patient care by ensuring dosimetry assessment is completed before the patient leaves the center after treatment administration. ow.ly/q8eM50VuLOQ #NuclearMedicine @MatthiasEiber

1.0K